What Andre Braugher's Story Can Help Us Understand About Lung Cancer

What was confirmed

Andre Braugher died on Monday, 11 December 2023, at 61. His publicist, Jennifer Allen, initially said he had died "after a brief illness."

Three days later Allen confirmed to CBS News that the cause was lung cancer. Variety reported the same, adding that he had only recently been diagnosed. No further details about his illness were released.

That short gap between diagnosis and death is the part of this story with something to teach. It is not unusual in lung cancer, and the reason is structural.

Two diseases under one name

NCI divides lung cancer into two groups that are treated very differently.

Non-small cell lung cancer accounts for most cases. It includes adenocarcinoma, squamous cell carcinoma, and large cell carcinoma. Treatment depends heavily on stage and on molecular testing of the tumor.

Small cell lung cancer is less common, grows and spreads faster, and is usually treated with chemotherapy and radiation rather than surgery.

Nothing has been made public about which type Braugher had, and this page does not guess. Our overview of lung cancer sets out both.

Why it is so often found late

The lungs have no pain nerves in the tissue itself. A tumor can grow to a substantial size before it presses on something that hurts or blocks something that matters.

NCI puts it directly: sometimes lung cancer causes no signs or symptoms at all, and may be found on a chest x-ray done for another reason.

SEER, the federal cancer surveillance program, shows the consequence. Only 24% of lung cancers are found while still confined to the lung. Fifty-one percent are found after they have spread to distant sites. Those proportions cover 2016 through 2022.

That is the mechanism behind a diagnosis arriving months before a death rather than years.

When to get checked

NCI says to check with a doctor about:

• Chest discomfort or pain.
• A cough that does not go away or gets worse over time.
• Trouble breathing.
• Wheezing.
• Any blood mixed into mucus brought up from the chest.
• Hoarseness.
• Loss of appetite.
• Weight loss for no known reason.
• Fatigue.
• Trouble swallowing.
• Swelling in the face or in the veins of the neck.

Two thresholds cut through that list. A cough that has lasted more than three weeks without clearing needs assessing, whatever the explanation seems to be. And any amount of blood in coughed-up mucus, even once, warrants a same-week appointment.

Hoarseness lasting more than three weeks belongs in the same category, because it can mean a tumor pressing on the nerve that controls the voice box.

Screening, and who it is for

There is a screening test, and it works for a defined group.

NCI reports that two randomized trials found low-dose CT scanning reduced lung cancer deaths by about 20% to 24%. One enrolled people aged 55 to 74 with at least 30 pack-years who still smoked or had quit within 15 years. The other enrolled people who were still smoking or had quit within the past 10 years and had smoked more than 15 cigarettes a day for over 25 years, or more than 10 a day for over 30 years. A pack-year means a pack a day for a year.

NCI also reports that chest x-rays and sputum tests have not been shown to reduce lung cancer deaths.

Screening is not free of cost. False-positive rates per round were 23.3% in one trial and 10.4% in the other, and 1.8% of participants who did not have cancer underwent an invasive procedure after a positive scan.

If your smoking history is anywhere near those thresholds, the conversation is worth having. Our page on lung cancer screening explains what the scan involves and who qualifies.

If it is not, screening is not currently recommended, and symptoms are what to act on.

What treatment involves now

For non-small cell lung cancer, molecular testing has changed the sequence. Tumors are checked for changes in genes such as EGFR and ALK, and for PD-L1, a protein that predicts response to immunotherapy. A tumor with a targetable change may be treated first with a tablet rather than chemotherapy.

Early-stage disease may be removed surgically. Locally advanced disease often combines chemotherapy, radiation, and immunotherapy. Advanced disease is usually treated with drugs, chosen by the tumor's molecular profile.

Anyone diagnosed with advanced non-small cell lung cancer should ask directly whether molecular testing has been done and what it showed. That result can change the first treatment offered.

What the registry shows

The American Cancer Society's 2026 projection is about 229,410 new lung and bronchus cancer diagnoses and 124,990 deaths in the United States. The median age at diagnosis is 71.

Lung cancer causes about one in five cancer deaths, more than any other cancer.

Five-year relative survival is 65.5% for localized disease, 38.2% for regional, and 10.5% for distant. Across all stages it is 29.5% for people diagnosed from 2016 through 2022 — up from about 12% in the mid-1970s.

Those figures pool both main types, every treatment era, and every smoking history. They describe a population, not a person.

What to keep in perspective

Nothing about Braugher's course predicts anyone else's. The type, stage, and molecular features of his cancer were never made public, and those are the things that drive outcomes.

A short interval between diagnosis and death also does not mean the diagnosis was missed. Lung cancer frequently presents late because of where it grows, not because someone failed to notice.

And the statistics on this page are backward-looking. They describe people diagnosed years ago, before the current generation of targeted drugs and immunotherapy had fully arrived.

What is actionable is smaller and more concrete: know the symptom list, act on a cough or hoarseness that will not clear, and find out whether screening applies to you.

Sources

• Variety: Andre Braugher's cause of death confirmed as lung cancer
• CBS News: Andre Braugher died of lung cancer, publicist says
• NCI PDQ: Lung Cancer Screening (Health Professional Version)
• NCI PDQ: Non-Small Cell Lung Cancer Treatment (Patient Version)
• NCI SEER Cancer Stat Facts: Lung and Bronchus Cancer

How this article was prepared

An AI-assisted editorial system helped prepare this page. No named medical reviewer has reviewed it unless one is listed.

See an error, old source, or unclear wording? Tell us.